Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline

scientific article

Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2967/JNUMED.110.081703
P932PMC publication ID3027353
P698PubMed publication ID21149488
P5875ResearchGate publication ID49675316

P50authorTodd E. PetersonQ42581285
P2093author name stringPing Zhao
Jason R Buck
H Charles Manning
Daniel Colvin
Eliot T McKinley
Ronald M Baldwin
Dewei Tang
Allie Fu
Ralph Adam Smith
Saffet Guleryuz
Mohammed Noor Tantawy
Matthew R Hight
Mohammed Sib Ansari
P2860cites workTranslocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular functionQ24296269
Regulation of translocator protein 18 kDa (TSPO) expression in health and disease statesQ24631648
Microwave-assisted Organic Synthesis of a High-affinity Pyrazolo-pyrimidinyl TSPO LigandQ33650978
Protein kinase C epsilon regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factorsQ33985241
Imaging of a glioma using peripheral benzodiazepine receptor ligandsQ34594710
DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterizationQ34769959
Distribution volume ratios without blood sampling from graphical analysis of PET dataQ36817029
Single-step high-yield radiosynthesis and evaluation of a sensitive 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PET.Q37105874
Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.Q37283568
Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06.Q37449735
Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterolQ40971557
Increase in omega 3 (peripheral-type benzodiazepine) binding site densities in different types of human brain tumours. A quantitative autoradiography studyQ41134387
Imaging of brain tumors using peripheral benzodiazepine receptor ligandsQ41837734
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomasQ42465912
PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report.Q43836608
Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancerQ44175762
Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106.Q46566192
Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain.Q46877954
Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brainQ48190498
Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptorsQ48193416
COMKAT: compartment model kinetic analysis tool.Q50126455
PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site.Q55484944
Isoquinoline and peripheral-type benzodiazepine binding in gliomas: implications for diagnostic imagingQ68097881
Synthesis and biology of a 7-nitro-2,1,3-benzoxadiazol-4-yl derivative of 2-phenylindole-3-acetamide: a fluorescent probe for the peripheral-type benzodiazepine receptorQ73589795
Targeted imaging of colonic tumors in smad3-/- mice discriminates cancer and inflammationQ80140819
Oral cancer, cigarette smoke and mitochondrial 18kDa translocator protein (TSPO) - In vitro, in vivo, salivary analysisQ82565843
Cigarette Smoke Decreases Salivary 18 kDa Translocator Protein Binding Affinity – in Association with Oxidative StressQ84277258
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)107-114
P577publication date2010-12-13
P1433published inThe Journal of Nuclear MedicineQ7743608
P1476titleQuantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline
P478volume52

Reverse relations

cites work (P2860)
Q37284537A novel reporter system for molecular imaging and high-throughput screening of anticancer drugs.
Q30945416Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.
Q64098498Anti-tumor effects and potential therapeutic response biomarkers in α-emitting -At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing
Q48226866Assessment of TSPO in a Rat Experimental Autoimmune Myocarditis Model: A Comparison Study between [18F]Fluoromethyl-PBR28 and [18F]CB251.
Q39181546Evaluation of TSPO PET Ligands [18F]VUIIS1009A and [18F]VUIIS1009B: Tracers for Cancer Imaging
Q34175347Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[(18)F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, a potent pyridazinoindole ligand for PET imaging of TSPO in cancer
Q38775990Imaging Macrophage Accumulation in a Murine Model of Chronic Pancreatitis with [(125)I]iodoDPA SPECT-CT.
Q41446521New structure-activity relationships of N-acetamide substituted pyrazolopyrimidines as pharmacological ligands of TSPO.
Q36079268Noninvasive molecular imaging of neuroinflammation
Q55456900Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18F-VUIIS1018A) to Image Glioma.
Q35827097Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study
Q35213599Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma
Q37991245Pretargeting: taking an alternate route for localizing radionuclides
Q27023605Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging
Q36081687Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.
Q39225240SPECT imaging of glioma with radioiodinated CLINDE: evidence from a mouse GL26 glioma model
Q34632108Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging
Q38640193TSPO PET for glioma imaging using the novel ligand (18)F-GE-180: first results in patients with glioblastoma
Q48194480TSPO PET using 18F-GE-180: a new perspective in neurooncology?
Q26748489TSPO expression in brain tumours: is TSPO a target for brain tumour imaging?
Q45401909The development of an automated and GMP compliant FASTlab™ Synthesis of [(18) F]GE-180; a radiotracer for imaging translocator protein (TSPO).
Q38014892The impact of positron emission tomography imaging on the clinical management of patients with epilepsy
Q30618244The role of astrocytes in CNS tumors: pre-clinical models and novel imaging approaches
Q38221277The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy.
Q39407528The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo
Q38617821Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model
Q38949384Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).
Q35048800Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity
Q39009678Translocator protein 18 kDa negatively regulates inflammation in microglia

Search more.